Explore more publications!
Hawaii Health Digest
Submit Press Release

Hawaii Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hawaii Health Digest.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 17, 2025

Portsmouth Square, Inc. Reports Q1 FY2026 Results; Hotel KPIs Up, Continued Stabilization in San Francisco, and ~$10.1 Million in Cash & Restricted Cash
November 17, 2025

Portsmouth Square, Inc. Reports Q1 FY2026 Results; Hotel KPIs Up, Continued Stabilization in San Francisco, and ~$10.1 Million in Cash & Restricted Cash

Indeterminate GlobeNewswire
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2025

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares
November 17, 2025

Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

Indeterminate GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
November 17, 2025

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
November 17, 2025

Candel Therapeutics to Host Virtual R&D Event on December 5, 2025

Indeterminate GlobeNewswire
Apyx Medical Corporation Announces Proposed Public Offering of Common Stock
November 17, 2025

Apyx Medical Corporation Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
November 17, 2025

Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer

Indeterminate GlobeNewswire
Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results
November 17, 2025

Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results

Indeterminate GlobeNewswire
Tilray Brands Publishes New Investor Presentation Highlighting Leadership Across Beverage, Cannabis and Wellness Industries, Showcasing Its Global Growth Strategy and Transformation into a Diversified CPG Powerhouse Shaping the Future of Consumer Products
November 17, 2025

Tilray Brands Publishes New Investor Presentation Highlighting Leadership Across Beverage, Cannabis and Wellness Industries, Showcasing Its Global Growth Strategy and Transformation into a Diversified CPG Powerhouse Shaping the Future of Consumer Products

Indeterminate GlobeNewswire
LifeMD Reports Third Quarter 2025 Results
November 17, 2025

LifeMD Reports Third Quarter 2025 Results

Indeterminate GlobeNewswire
Invivyd Announces Proposed Public Offering of Common Stock
November 17, 2025

Invivyd Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
Results of Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics
November 17, 2025

Results of Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) in Children with Achondroplasia Published in JAMA Pediatrics

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Fulfilling Order for Customized Spider Silk Application from Leading Performance Sports Brand
November 17, 2025

Kraig Biocraft Laboratories Fulfilling Order for Customized Spider Silk Application from Leading Performance Sports Brand

Indeterminate GlobeNewswire
Protext Mobility, Inc. (OTC: TXTM) Announces Strategic TruLeaf Partnership & Next-Level Innovation
November 17, 2025

Protext Mobility, Inc. (OTC: TXTM) Announces Strategic TruLeaf Partnership & Next-Level Innovation

Indeterminate GlobeNewswire
AI to Revolutionize Pharma with 31.7% CAGR Growth
November 17, 2025

AI to Revolutionize Pharma with 31.7% CAGR Growth

Indeterminate GlobeNewswire
Neocis Unveils Next-Generation AI-Powered Robotic System for Dental Implants
November 17, 2025

Neocis Unveils Next-Generation AI-Powered Robotic System for Dental Implants

Indeterminate GlobeNewswire
Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape | DelveInsight
November 17, 2025

Dry Age-related Macular Degeneration Market Poised for Rapid Growth During the Forecast Period (2025–2034) Amid Expanding Treatment Landscape | DelveInsight

Indeterminate GlobeNewswire
Global Contraceptive Devices Market is Set to Accelerate at a CAGR of ~6% by 2032, as Demand for Advanced Birth Control Solutions Rises | DelveInsight
November 17, 2025

Global Contraceptive Devices Market is Set to Accelerate at a CAGR of ~6% by 2032, as Demand for Advanced Birth Control Solutions Rises | DelveInsight

Indeterminate GlobeNewswire
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
November 17, 2025

Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)

Indeterminate GlobeNewswire
FDA Grants Fast Track Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
November 17, 2025

FDA Grants Fast Track Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions